1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Organoids Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Organoids Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Organoids Market Regional Analysis
6.2 North America Organoids Market Revenue 2021-2031 (US$ Million)
6.3 North America Organoids Market Forecast Analysis
7. North America Organoids Market Analysis – by Type
7.1 Intestine
- 7.1.1 Overview
- 7.1.2 Intestine: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Liver
- 7.2.1 Overview
- 7.2.2 Liver: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Pancreas
- 7.4.1 Overview
- 7.4.2 Pancreas: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Lung
- 7.5.1 Overview
- 7.5.2 Lung: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Brain
- 7.6.1 Overview
- 7.6.2 Brain: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Kidney
- 7.7.1 Overview
- 7.7.2 Kidney: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others : North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Organoids Market Analysis – by Application
8.1 Developmental Biology Disease
- 8.1.1 Overview
- 8.1.2 Developmental Biology Disease: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Pathology of Infectious Disease
- 8.2.1 Overview
- 8.2.2 Pathology of Infectious Disease: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Regenerative Medicine
- 8.3.1 Overview
- 8.3.2 Regenerative Medicine: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Drug Toxicity and Efficacy Testing
- 8.4.1 Overview
- 8.4.2 Drug Toxicity and Efficacy Testing: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Drug Discovery and Personalized Medicine
- 8.5.1 Overview
- 8.5.2 Drug Discovery and Personalized Medicine: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Organoids Market Analysis – by Source
9.1 Pluripotent Stem Cells
- 9.1.1 Overview
- 9.1.2 Pluripotent Stem Cells: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Organ-Specific Adult Stem Cell
- 9.2.1 Overview
- 9.2.2 Organ-Specific Adult Stem Cell: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Organoids Market Analysis – by Offering
10.1 Instruments
- 10.1.1 Overview
- 10.1.2 Instruments: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Consumables
- 10.2.1 Overview
- 10.2.2 Consumables: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Services
- 10.3.1 Overview
- 10.3.2 Services: North America Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. North America Organoids Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Organoids Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 11.2.1.1 North America Organoids Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Organoids Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 US: North America Organoids Market Breakdown, by Type
- 11.2.1.1.2 US: North America Organoids Market Breakdown, by Application
- 11.2.1.1.3 US: North America Organoids Market Breakdown, by Source
- 11.2.1.1.4 US: North America Organoids Market Breakdown, by Offering
- 11.2.1.2 Canada:
North America Organoids Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.2.1 Canada: North America Organoids Market Breakdown, by Type
- 11.2.1.2.2 Canada: North America Organoids Market Breakdown, by Application
- 11.2.1.2.3 Canada: North America Organoids Market Breakdown, by Source
- 11.2.1.2.4 Canada: North America Organoids Market Breakdown, by Offering
- 11.2.1.3 Mexico:
North America Organoids Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.3.1 Mexico: North America Organoids Market Breakdown, by Type
- 11.2.1.3.2 Mexico: North America Organoids Market Breakdown, by Application
- 11.2.1.3.3 Mexico: North America Organoids Market Breakdown, by Source
- 11.2.1.3.4 Mexico: North America Organoids Market Breakdown, by Offering
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 STEMCELL Technologies Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Molecular Devices, LLC.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Hubrecht Organoid Technology
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Definigen
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Organoid Therapeutics
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Corning Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Merck KGaA
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 InSphero
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 ACRO Biosystems
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Bio-Techne Corp
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 SUN bioscience SA
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments
14.13 ORGANOID SCIENCES Co., Ltd.
- 14.13.1 Key Facts
- 14.13.2 Business Description
- 14.13.3 Products and Services
- 14.13.4 Financial Overview
- 14.13.5 SWOT Analysis
- 14.13.6 Key Developments
14.14 Crown Bioscience Inc
- 14.14.1 Key Facts
- 14.14.2 Business Description
- 14.14.3 Products and Services
- 14.14.4 Financial Overview
- 14.14.5 SWOT Analysis
- 14.14.6 Key Developments
14.15 Sartorius AG
- 14.15.1 Key Facts
- 14.15.2 Business Description
- 14.15.3 Products and Services
- 14.15.4 Financial Overview
- 14.15.5 SWOT Analysis
- 14.15.6 Key Developments
14.16 3D Biotek LLC
- 14.16.1 Key Facts
- 14.16.2 Business Description
- 14.16.3 Products and Services
- 14.16.4 Financial Overview
- 14.16.5 SWOT Analysis
- 14.16.6 Key Developments
14.17 Prellis Biologics Inc.
- 14.17.1 Key Facts
- 14.17.2 Business Description
- 14.17.3 Products and Services
- 14.17.4 Financial Overview
- 14.17.5 SWOT Analysis
- 14.17.6 Key Developments
14.18 3Dnamics Inc.
- 14.18.1 Key Facts
- 14.18.2 Business Description
- 14.18.3 Products and Services
- 14.18.4 Financial Overview
- 14.18.5 SWOT Analysis
- 14.18.6 Key Developments
14.19 Cellesce Ltd
- 14.19.1 Key Facts
- 14.19.2 Business Description
- 14.19.3 Products and Services
- 14.19.4 Financial Overview
- 14.19.5 SWOT Analysis
- 14.19.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations